SEC Filing • AMGEN INC
AMGEN INC (AMGN) files 10-Q for Q3 2025
👤 SEC
📅 Nov 4, 2025 11:59 PM (5 months ago)
🐂 Somewhat positive (75%)
AI Sentiment Analysis
Based on analyst estimates, the expected revenue for Amgen in Q3 2025 was approximately $9.4 billion and the expected EPS was $5.75. Amgen's reported revenue of $9.557 billion beat expectations by approximately $157 million. The reported EPS of $5.93 also beat expectations by $0.18.